AMSTERDAM, April 6 /PRNewswire/ --

- SLA Centennial Observance Honors Cell, The Lancet and Other Key Elsevier Journals

Twenty journals published by Elsevier (many on behalf of renowned societies) have been nominated for the Special Library Association's (SLA) Top 100 Journals in Biology and Medicine. The Top 100 list is compiled by the 680-plus members of the Biomedical and Life Sciences Division (DBIO) on the most influential journals in biology and medicine over the last 100 years. The Journal of the Century and the winners of this prestigious award will be announced on Tuesday, June 16th, at the Centennial Conference of the Special Libraries Association in Washington DC.

Established in 1909 to serve librarians specialized in business, government, social agencies, and academia, the SLA is now an 11,000-member professional organization of subject specialist librarians, information managers, and publishing industry representatives. Each topical division has contributed a Centennial-themed event throughout the year. In 2008, DBIO convened an international panel of nine eminent subject experts to compile a ballot for an electronic poll of SLA members concerning the 100 most influential journals of biology and medicine over the past century of SLA's existence.

We are tremendously honored and proud to have so many journals and society partners recognized for excellence by the SLA's community of information pioneers, remarked Youngsuk Y.S. Chi, Vice Chairman at Elsevier, who will attend the June 16th award ceremony. All of the journals that are on this list are outstanding, reflecting a thriving and fiercely competitive biomedical and life sciences research community and the publishing community's support that is driven to advance scientific discovery.

The DBIO 100, the 100 Most Influential Journals in Biology Medicine over the last 100 Years as voted by the BioMedical Life Sciences Division of the Special Libraries Association on the Occasion of its Centennial include 20 Elsevier journals, many published in partnership with prestigious societies:

- The American Journal of Human Genetics, Cell Press with the American Society of Human Genetics - American Journal of Obstetrics Gynecology, Elsevier with the American Gynecological and Obstetrical Society - Animal Behaviour, Elsevier with the Association for the Study of Animal Behaviour, UK, and the Animal Behavior Society, US - Annals of Emergency Medicine, Elsevier with the American College of Emergency Physicians - Archives of Physical Medicine and Rehabilitation, Elsevier with the American Congress of Rehabilitation - Biochimica et Biophysica Acta, Elsevier - Brain and Cognition, Elsevier together with several US and international cognitive neuropsychology societies - Cell, Cell Press, Elsevier - Current Biology, Cell Press, Elsevier - Developmental Biology, Elsevier with the Society for Developmental Biology - Gastroenterology, Elsevier with the American Gastroenterological Association - The Journal of Allergy and Clinical Immunology, Elsevier with the American Academy of Allergy, Asthma and Immunology - Journal of Experimental Marine Biology and Ecology, Elsevier - Journal of Human Evolution Elsevier - Journal of Molecular Biology Elsevier - Journal of the American Academy of Dermatology, Elsevier with the American Academy of Dermatology - Journal of the American College of Surgeons, Elsevier with the American College of Surgeons - The Journal of Urology, Elsevier with the American Urological Association - The Lancet Elsevier - Virology Elsevier

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (, MD Consult (, Scopus (, bibliographic databases, and online reference works.

Elsevier ( is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Ylann Schemm Phone +31-20-485-2025 E-mail

Ylann Schemm, Phone +31-20-485-2025, E-mail